Key result
Bethesda + 40 report highlights stalled or reversed CVD mortality declines, urging early childhood interventions.
Why the study?
Cardiovascular disease mortality declines have decelerated, ended, or reversed, with heart failure mortality increasing, prompting a need to examine outcomes of the 1978 Bethesda Conference and understand the current environment.
This symposium report highlights the deceleration in cardiovascular mortality decline and the rising rates of heart failure, emphasizing the need for early interventions and research.
May support earlier primordial prevention; leaves open effective strategies to reverse decelerating CVD mortality declines.
More than 40 years after the 1978 Bethesda Conference on the Declining Mortality from Coronary Heart Disease provided the scientific community with a blueprint for systematic analysis to understand declining rates of coronary heart disease, there are indications the decline has ended or even reversed despite advances in our knowledge about the condition and treatment. Recent data show a more complex situation, with mortality rates for overall cardiovascular disease, including coronary heart disease and stroke, decelerating, whereas those for heart failure are increasing. To mark the 40th anniversary of the Bethesda Conference, the National Heart, Lung, and Blood Institute and the American Heart Association cosponsored the "Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40" symposium. The objective was to examine the immediate and long-term outcomes of the 1978 conference and understand the current environment. Symposium themes included trends and future projections in cardiovascular disease (in the United States and internationally), the evolving obesity and diabetes epidemics, and harnessing emerging and innovative opportunities to preserve and promote cardiovascular health and prevent cardiovascular disease. In addition, participant-led discussion explored the challenges and barriers in promoting cardiovascular health across the lifespan and established a potential framework for observational research and interventions that would begin in early childhood (or ideally in utero). This report summarizes the relevant research, policy, and practice opportunities discussed at the symposium.
No takes yet. Share an insight, caveat, or question.
Goff et al. (2021) conducted a review in Cardiovascular disease. The Bethesda + 40 symposium report highlights that cardiovascular disease mortality declines have decelerated or reversed, emphasizing the need for interventions starting in early childhood.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: